Kaposi varicelliform eruption in patients with autoimmune bullous dermatoses

Julia Lehman, Rokea A. el-Azhary

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background: Viral superinfection of skin affected by preceding dermatosis has been studied extensively in eczema and reported anecdotally in pemphigus. Little is known about its involvement and complications in patients with other immunobullous diseases. Methods: To investigate clinical features and complications of viral superinfection in patients with immunobullous diseases, we performed a retrospective chart review. Results: We identified 12 patients with immunobullous diseases (linear immunoglobulin A bullous dermatosis, n = 2; pemphigoid, n = 3; pemphigus, n = 7) and superinfection by herpes simplex virus 1 (n = 9) or 2 (n = 3). Complications included inpatient hospitalization for intensive management of skin lesions during viral flare (n = 6), herpes keratitis (n = 1), and death due to sepsis (n = 1). Five patients previously had a skin swab negative for herpes simplex virus polymerase chain reaction before a positive test. Nine patients were taking systemic corticosteroids or corticosteroid-sparing agents at herpetic infection; two with linear immunoglobulin A bullous dermatosis and one with a new diagnosis of pemphigus vulgaris had not. Conclusions: Viral superinfection is a potentially serious complication in patients with immunobullous diseases. Clinicians should have a high index of suspicion for this phenomenon, even when patients are not otherwise immunosuppressed or when previous viral skin assays have been negative.

Original languageEnglish (US)
Pages (from-to)e136-e140
JournalInternational Journal of Dermatology
Volume55
Issue number3
DOIs
StatePublished - Mar 1 2016

Fingerprint

Kaposi Varicelliform Eruption
Vesiculobullous Skin Diseases
Superinfection
Pemphigus
Skin
Immunoglobulin A
Adrenal Cortex Hormones
Bullous Pemphigoid
Keratitis
Eczema
Human Herpesvirus 1
Simplexvirus
Skin Diseases
Inpatients
Sepsis
Hospitalization
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Dermatology

Cite this

Kaposi varicelliform eruption in patients with autoimmune bullous dermatoses. / Lehman, Julia; el-Azhary, Rokea A.

In: International Journal of Dermatology, Vol. 55, No. 3, 01.03.2016, p. e136-e140.

Research output: Contribution to journalArticle

@article{67d897e44cbd4aeb84c0cab70760c276,
title = "Kaposi varicelliform eruption in patients with autoimmune bullous dermatoses",
abstract = "Background: Viral superinfection of skin affected by preceding dermatosis has been studied extensively in eczema and reported anecdotally in pemphigus. Little is known about its involvement and complications in patients with other immunobullous diseases. Methods: To investigate clinical features and complications of viral superinfection in patients with immunobullous diseases, we performed a retrospective chart review. Results: We identified 12 patients with immunobullous diseases (linear immunoglobulin A bullous dermatosis, n = 2; pemphigoid, n = 3; pemphigus, n = 7) and superinfection by herpes simplex virus 1 (n = 9) or 2 (n = 3). Complications included inpatient hospitalization for intensive management of skin lesions during viral flare (n = 6), herpes keratitis (n = 1), and death due to sepsis (n = 1). Five patients previously had a skin swab negative for herpes simplex virus polymerase chain reaction before a positive test. Nine patients were taking systemic corticosteroids or corticosteroid-sparing agents at herpetic infection; two with linear immunoglobulin A bullous dermatosis and one with a new diagnosis of pemphigus vulgaris had not. Conclusions: Viral superinfection is a potentially serious complication in patients with immunobullous diseases. Clinicians should have a high index of suspicion for this phenomenon, even when patients are not otherwise immunosuppressed or when previous viral skin assays have been negative.",
author = "Julia Lehman and el-Azhary, {Rokea A.}",
year = "2016",
month = "3",
day = "1",
doi = "10.1111/ijd.13091",
language = "English (US)",
volume = "55",
pages = "e136--e140",
journal = "International Journal of Dermatology",
issn = "0011-9059",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Kaposi varicelliform eruption in patients with autoimmune bullous dermatoses

AU - Lehman, Julia

AU - el-Azhary, Rokea A.

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Background: Viral superinfection of skin affected by preceding dermatosis has been studied extensively in eczema and reported anecdotally in pemphigus. Little is known about its involvement and complications in patients with other immunobullous diseases. Methods: To investigate clinical features and complications of viral superinfection in patients with immunobullous diseases, we performed a retrospective chart review. Results: We identified 12 patients with immunobullous diseases (linear immunoglobulin A bullous dermatosis, n = 2; pemphigoid, n = 3; pemphigus, n = 7) and superinfection by herpes simplex virus 1 (n = 9) or 2 (n = 3). Complications included inpatient hospitalization for intensive management of skin lesions during viral flare (n = 6), herpes keratitis (n = 1), and death due to sepsis (n = 1). Five patients previously had a skin swab negative for herpes simplex virus polymerase chain reaction before a positive test. Nine patients were taking systemic corticosteroids or corticosteroid-sparing agents at herpetic infection; two with linear immunoglobulin A bullous dermatosis and one with a new diagnosis of pemphigus vulgaris had not. Conclusions: Viral superinfection is a potentially serious complication in patients with immunobullous diseases. Clinicians should have a high index of suspicion for this phenomenon, even when patients are not otherwise immunosuppressed or when previous viral skin assays have been negative.

AB - Background: Viral superinfection of skin affected by preceding dermatosis has been studied extensively in eczema and reported anecdotally in pemphigus. Little is known about its involvement and complications in patients with other immunobullous diseases. Methods: To investigate clinical features and complications of viral superinfection in patients with immunobullous diseases, we performed a retrospective chart review. Results: We identified 12 patients with immunobullous diseases (linear immunoglobulin A bullous dermatosis, n = 2; pemphigoid, n = 3; pemphigus, n = 7) and superinfection by herpes simplex virus 1 (n = 9) or 2 (n = 3). Complications included inpatient hospitalization for intensive management of skin lesions during viral flare (n = 6), herpes keratitis (n = 1), and death due to sepsis (n = 1). Five patients previously had a skin swab negative for herpes simplex virus polymerase chain reaction before a positive test. Nine patients were taking systemic corticosteroids or corticosteroid-sparing agents at herpetic infection; two with linear immunoglobulin A bullous dermatosis and one with a new diagnosis of pemphigus vulgaris had not. Conclusions: Viral superinfection is a potentially serious complication in patients with immunobullous diseases. Clinicians should have a high index of suspicion for this phenomenon, even when patients are not otherwise immunosuppressed or when previous viral skin assays have been negative.

UR - http://www.scopus.com/inward/record.url?scp=84959568215&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959568215&partnerID=8YFLogxK

U2 - 10.1111/ijd.13091

DO - 10.1111/ijd.13091

M3 - Article

C2 - 26500144

AN - SCOPUS:84959568215

VL - 55

SP - e136-e140

JO - International Journal of Dermatology

JF - International Journal of Dermatology

SN - 0011-9059

IS - 3

ER -